本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Theravance Biopharma Inc.

10.29
-0.0800-0.77%
盤後10.290.00000.00%16:05 EDT
成交量:23.17萬
成交額:237.54萬
市值:5.15億
市盈率:-8.91
高:10.41
開:10.32
低:10.11
收:10.37
資料載入中...
2020/06/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/10

重要事件披露

8-K - Current report
2020/05/08

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/29

重要事件披露

8-K - Current report
2020/04/09

重要事件披露

Current report, items 8.01 and 9.01
2020/03/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/03/03

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/24

重要事件披露

Current report, items 2.02 and 9.01
2020/02/18

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/13

重要事件披露

Current report, items 1.01, 2.02, 8.01, and 9.01
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

重要事件披露

Current report, item 5.02
2020/01/28

超過5%披露

Statement of acquisition of beneficial ownership by individuals